AU4547896A - 4-oxo-2-butenoic acid derivatives - Google Patents

4-oxo-2-butenoic acid derivatives

Info

Publication number
AU4547896A
AU4547896A AU45478/96A AU4547896A AU4547896A AU 4547896 A AU4547896 A AU 4547896A AU 45478/96 A AU45478/96 A AU 45478/96A AU 4547896 A AU4547896 A AU 4547896A AU 4547896 A AU4547896 A AU 4547896A
Authority
AU
Australia
Prior art keywords
oxo
acid derivatives
butenoic acid
butenoic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45478/96A
Inventor
Masaki Ihara
Kiyofumi Ishikawa
Toshio Nagase
Masaru Nishikibe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of AU4547896A publication Critical patent/AU4547896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
AU45478/96A 1995-02-03 1996-02-01 4-oxo-2-butenoic acid derivatives Abandoned AU4547896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3935795 1995-02-03
JP7-39357 1995-02-03
PCT/JP1996/000195 WO1996023773A1 (en) 1995-02-03 1996-02-01 4-oxo-2-butenoic acid derivatives

Publications (1)

Publication Number Publication Date
AU4547896A true AU4547896A (en) 1996-08-21

Family

ID=12550829

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45478/96A Abandoned AU4547896A (en) 1995-02-03 1996-02-01 4-oxo-2-butenoic acid derivatives

Country Status (2)

Country Link
AU (1) AU4547896A (en)
WO (1) WO1996023773A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09501920A (en) * 1993-08-19 1997-02-25 ワーナー−ランバート・コンパニー Non-peptide endothelin antagonist ▲ I ▼
US5922759A (en) * 1996-06-21 1999-07-13 Warner-Lambert Company Butenolide endothelin antagonists
AU6603996A (en) * 1995-08-24 1997-03-19 Warner-Lambert Company Furanone endothelin antagonists
NZ331801A (en) * 1996-02-19 2001-01-26 Japan Tobacco Inc Therapeutic agent for diabetes
US5891892A (en) * 1996-10-29 1999-04-06 Warner-Lambert Company Small molecule biaryl compounds as inhibitors of endothelin converting enzyme
DE19653037A1 (en) * 1996-12-19 1998-06-25 Merck Patent Gmbh Endothelin receptor antagonists
US6420375B1 (en) 1997-02-21 2002-07-16 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3058945B2 (en) * 1990-10-26 2000-07-04 三共株式会社 N- (3,3-disubstituted acryloyl) piperazine derivatives
JPH0647575A (en) * 1992-08-03 1994-02-22 Fanuc Ltd Optical scanning type laser beam machine
JPH06157520A (en) * 1992-11-13 1994-06-03 Kirin Brewery Co Ltd New substance hq24
DE4414792A1 (en) * 1993-08-11 1995-02-16 Bayer Ag Medicaments containing 1-thiocarbamoyl-5-hydroxypyrazoles and their use as agents for combating septic shock

Also Published As

Publication number Publication date
WO1996023773A1 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
AU4665596A (en) Pyrazolylbenzoyl derivatives
GB9504065D0 (en) Poly-pyrrolecarboxamidonaphthalenic acid derivatives
AU7626596A (en) Oxymethoxy-3-aryl-pyrone derivatives
AU1195897A (en) Heteroarylcarboxamide derivatives
AU4086296A (en) Indolepiperidine derivatives
AU7053296A (en) Purin-6-one derivatives
AU667757B2 (en) Quinolone- and naphthyridonecarboxylic acid derivatives
AU5779196A (en) Novel 2-amino-3-phenylpropionic acid derivatives
AU4875296A (en) Isoxazolyl-benzoyl derivatives
AU5763596A (en) 2-ureido-benzamide derivatives
AU7930394A (en) Pyrimidinyl-glutamic acid derivatives
AU1559199A (en) Isothiazolcarboxylic acid derivatives
AU6191796A (en) Sulfonyl- or sulfinylbenzoylguanidine derivatives
AU7084796A (en) Diarylalkenylamine derivatives
AU5497796A (en) New hydroximic acid derivatives
AU5052296A (en) 4-indolylpiperazinyl derivatives
AU4547796A (en) Hexahydropyrazinoquinoline derivatives
AU4211296A (en) 4-aminobenzoylguanidine derivatives
AU6929696A (en) Pyrazol-4-ylbenzoyl derivatives
AU4547896A (en) 4-oxo-2-butenoic acid derivatives
AU4547396A (en) Thioquinoline derivatives
AU5758894A (en) Acyloxyhexanoic acid derivatives
AU6214896A (en) Alkenyl-benzoylguanidine derivatives
AU2629295A (en) Trifluoromethylquinolinecarboxylic acid derivative
AU4220096A (en) 4-mercaptobenzoylguanidine derivatives